BioSpace News Archive

VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, is pleased to announce that it has completed in silico analyses and believes that it has successfully identified a corona virus (COVID-19) vaccine candidate (“Vaccine Candidate”).

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders, today announced that Bruce Steel, Equillium’s chief executive officer, will present at 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020.

Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today reported its financial results for the year ended December 31, 2019.

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2019.

Recommendations align with protocols outlined in ImpediMed’s Lymphedema Prevention Program [13-February-2020] CARLSBAD, Calif. , and BRISBANE, Australia , Feb. 13, 2020 /PRNewswire/ -- ImpediMed Limited (ASX.IPD), a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscop

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced its financial results for the three and six months ended December 31, 2019 and provided a corporate update.

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it has completed the first closing under a recently executed Securities Purchase Agreement with Innoviva, Inc.

Decision Resources Group, www.decisionresourcesgroup.com, a premier provider of high-value healthcare data, analytics, and insights products and services to the healthcare industry, has been named as the new partner for the Health Industry Distributors Association industry data program.

Feb. 13, 2020 13:00 UTC Initial Tranche Extends Cash Runway into 2022, Beyond Planned Clinical Data Readouts for Two Lead Programs CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of a $60 million senior secured loan facility with Oxford Finance LLC, a specialty finance firm providing senior debt to life sciences and healthcare service compani

Ohana Biosciences announced that Amber Salzman, Ph.D., President and Chief Executive Officer of Ohana, will present a company overview at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at 1:45 p.m. EST in New York, NY.